US 7122552
Inhibitors of JAK and CDK2 protein kinases
granted A61PA61P11/06A61P19/02
Quick answer
US patent 7122552 (Inhibitors of JAK and CDK2 protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P11/06, A61P19/02, A61P21/04, A61P25/00